Forget McGregor-Mayweather. The biotech world has been waiting for months to hear about Novartis’ pricing decision for Kymriah, its just-approved CAR-T therapy for cancer. That interest turned into anxiety days earlier when Gilead announced its purchase of Kite, given that Kite is expected to ...
Stories Related to A $475,000 Price Tag For A New Cancer Drug
STAT, Raw Story: Science
Thu, 08/31/2017 - 9:47pm
Topics: science
RELATED ARTICLES
- E.P.A. Could Make Thousands of Pollution Deaths Vanish by Changing Its Math
The Environmental Protection Agency plans to adopt a new method for projecting the future health risks of air pollution that experts have said is not scientifically sound. More - ‘Earthworm Dilemma’ Has Climate Scientists Racing to Keep Up
Worms are wriggling into Earth’s northernmost forests, creating major unknowns for climate-change models. More - Fighting Ebola When Mourners Fight the Responders
An Ebola outbreak in eastern Congo — the second-largest in history — is escalating in part because locals don’t trust health workers and government officials. More - Fighting Ebola When Mourners Fight the Responders
An Ebola outbreak in eastern Congo — the second-largest in history — is escalating in part because locals don’t trust health workers and government officials. More - What Does It Really Mean to Be 6 Weeks Pregnant?
So-called ‘heartbeat’ legislation restricting abortion as early as six weeks into pregnancy has started a conversation about when most women actually learn that they’re pregnant. More - In Cities Where It Once Reigned, Heroin Is Disappearing
The rise of the more potent fentanyl in its place has put a generation of older users, who had managed their addiction, at far greater risk of overdose. More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more